LoginSignup
BIO

Biogaia

Stock
Stock
ISIN: SE0017769995
Ticker: BIOG B
SE0017769995
BIOG B

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Biogaia has so far distributed $0.707 in 2025. 

$0.218

CHART BY

Frequently asked questions

What is Biogaia's market capitalization?

The market capitalization of Biogaia is $1.13B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Biogaia's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Biogaia is 34.11. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Biogaia?

Biogaia's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.323. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Biogaia's stock?

Currently, 3 analysts cover Biogaia's stock, with a consensus target price of $13.95. Analyst ratings provide insights into the stock's expected performance.

What is Biogaia's revenue over the trailing twelve months?

Over the trailing twelve months, Biogaia reported a revenue of $149.55M.

What is the EBITDA for Biogaia?

Biogaia's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $50.29M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Biogaia?

Biogaia has a free cash flow of $37.03M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Biogaia have, and what sector and industry does it belong to?

Biogaia employs approximately 225 people. It operates in the Health Care sector, specifically within the Other Pharmaceuticals industry.

What is the free float of Biogaia's shares?

The free float of Biogaia is 86.19M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.13B
EPS (TTM) 
$0.323
Free Float 
86.19M
P/E ratio (TTM) 
34.11
Revenue (TTM) 
$149.55M
EBITDA (TTM) 
$50.29M
Free Cashflow (TTM) 
$37.03M

Pricing

1D span
$10.42$11.18
52W span
$8.984$12.74

Analyst Ratings

The price target is $13.95 and the stock is covered by 3 analysts.

Buy

3

Hold

0

Sell

0

Information

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.

Employees
225
Industries
Other Pharmaceuticals
Sector
Health Care

Identifier

ISIN
SE0017769995
Primary Ticker
BIOG B

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin